Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» venture capital
venture capital
To back, or back away from, digital health?
EP Vantage
Wed, 06/15/22 - 10:40 am
Medtech
digital health
funding
venture capital
Biofourmis
Mindmaze
Viz AI
Hello Heart
Osso VR
Enable Injections
Billiontoone
Nalu Medical
Visby Medical
Memed Diagnostics
With biotech in retreat, Third Rock raises $1B for life sciences investing
BioPharma Dive
Wed, 06/15/22 - 10:36 am
Third Rock
venture capital
funding
With stacked to-do list, ImCheck checks off next funding round, refueling with about $101M
Fierce Biotech
Mon, 06/13/22 - 10:26 am
ImCheck
funding
venture capital
Pfizer
Bonfire of biotech: Forbion aims €470M late-stage fund at bets enabled by market crash
Fierce Biotech
Fri, 06/10/22 - 10:46 am
Forbion
venture capital
funding
Locus pulls in a modest Series B as it attempts to emulate oncology's precision medicine model in antibacterials
Endpoints
Wed, 05/18/22 - 10:32 am
Locus Biosciences
venture capital
funding
antibiotics
antibacterials
R&D
Lonza secures deal with ALSA Ventures to support its portfolio of biotechs
Biopharma Reporter
Mon, 05/16/22 - 10:19 am
Lonza
ALSA Ventures
venture capital
CDMOs
Novo Nordisk forges close ties with biotech VC Flagship
Pharmaforum
Wed, 05/11/22 - 10:39 am
Novo Nordisk
R&D
Flagship Pioneering
venture capital
Riding on wave of clinical trial reforms, machine learning startup bags $50M to create 'digital twins'
Endpoints
Tue, 04/19/22 - 11:42 pm
machine learning
artificial intelligence
clinical trials
venture capital
Merck KGaA
Carlyle's acquisition of Abingworth brings $2 billion to fuel life science investments
Fierce Biotech
Tue, 04/12/22 - 08:57 pm
Carlyle Group
Abingworth
venture capital
Another RA-backed biotech hits Nasdaq as public market stirs again after a bruising first quarter
Endpoints
Fri, 03/25/22 - 10:29 am
AN2 Therapeutics
lung disease
funding
RA Capital
venture capital
IPOs
Bayer-backed Affini-T snags $175M to enter increasingly crowded KRAS-cancer field
Fierce Biotech
Tue, 03/22/22 - 10:09 am
Affini-T Therapeutics
venture capital
Bayer
KRAS
Plexium nabs $102M for protein degradation work weeks after $500M Amgen tie-up
Fierce Biotech
Wed, 02/23/22 - 10:34 am
Plexium
Amgen
protein degradation
venture capital
funding
Hunting for cutting-edge biotech, Fujifilm sets up early-stage VC fund
Fierce Biotech
Fri, 02/11/22 - 10:32 am
Fujifilm
venture capital
funding
Medtech scores its biggest-ever venture haul
EP Vantage
Mon, 01/17/22 - 10:42 am
devices
Medtech
venture capital
Caris Life Sciences
CMR Surgical
Freenome
Element Biosciences
Quanta
Imperative Care
Exo
Cue Health
Intervenn Biosciences
In 2021 it paid to stay private for biotech
EP Vantage
Wed, 01/5/22 - 10:38 am
biotech
funding
venture capital
Science, talent, money: Eir raises $138M VC fund to fill gap in Nordic life science scene
Fierce Biotech
Thu, 12/9/21 - 10:34 am
Eir
funding
Nordic
venture capital
Sweden
Denmark
Europe
Merck KGaA's venture arm is ready to make new investments, raising more than $675M to get things going
Endpoints
Wed, 12/8/21 - 10:41 am
Merck KGaA
venture capital
M Ventures
Europe
Apollo's mission to extend human health span gets $180M boost, giving VC fund a launchpad for age-related disease biotechs
Fierce Biotech
Wed, 12/1/21 - 10:26 am
Apollo Health Ventures
age-related disease
funding
venture capital
Signet Therapeutics gets a $10M top-up for next-gen cancer bets
Fierce Biotech
Fri, 10/29/21 - 11:07 am
Signet Therapeutics
funding
venture capital
China
cancer
oncology
Frazier has raised an $830M public life science fund. Here's how it plans to invest the cash
Fierce Biotech
Thu, 10/28/21 - 10:13 pm
Frazier Healthcare
funding
life sciences
venture capital
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »